Affymax's Acquisition

Affymax was acquired by Apax Partners, MPM Capital and Sprout Group on August 15, 2001.

Affymax is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. The companys product candidate, Hematide, is curre…

Articles about Affymax's Acquisition: